Juan Francisco Oteo
Overview
Explore the profile of Juan Francisco Oteo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalvez-Garcia A, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, Cheema A, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Dec;
PMID: 39722415
Introduction And Objectives: The Valve Academic Research Consortium (VARC)-3 definition of the early safety (ES) composite endpoint after transcatheter aortic valve replacement (TAVR) lacks clinical validation. The aim of this...
2.
Nuche J, Mesnier J, Ternacle J, Rezaei E, Campelo-Parada F, Urena M, et al.
Can J Cardiol
. 2024 Dec;
PMID: 39710301
Background: Patients with symptomatic aortic stenosis are a vulnerable population with associated cardiac damage and a significant comorbidity burden. In this study we aimed to determine the rate, factors associated...
3.
Mengi S, Cepas-Guillen P, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, et al.
Can J Cardiol
. 2024 Dec;
PMID: 39667494
Background: Atrial fibrillation (AF) has been identified as a marker of advanced cardiac damage in patients with aortic stenosis. However, the factors associated with poorer outcomes among AF patients in...
4.
Avvedimento M, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, Cheema A, et al.
Circ Cardiovasc Interv
. 2024 Oct;
18(1):e014800.
PMID: 39475194
Background: The Valve Academic Research Consortium for High Bleeding Risk (VARC-HBR) has recently introduced a consensus document that outlines risk factors to identify high bleeding risk in patients undergoing transcatheter...
5.
Tirado-Conte G, Panagides V, Vergara-Uzcategui C, Fernandez G, Vilchez J, Cepas-Guillen P, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
PMID: 39251129
Introduction And Objectives: Thrombocytopenia frequently occurs after transcatheter aortic valve implantation (TAVI) but its impact is poorly understood. We aimed to analyze the incidence, clinical impact, and predictors of acquired...
6.
Gabani R, Brugaletta S, Bujak K, Perez-Vizcayno M, Jimenez-Quevedo P, Arevalos V, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Aug;
PMID: 39187234
Introduction And Objectives: Impact of gender on long-term outcomes after transcatheter aortic valve implantation (TAVI) remains uncertain. We aimed to investigate gender-specific differences in TAVI and its impact on outcomes....
7.
Vela Martin P, Arellano Serrano C, Lorente Ros A, Oteo J, Garcia-Touchard A
J Cardiovasc Dev Dis
. 2024 Jul;
11(7).
PMID: 39057620
Optical Coherence Tomography (OCT) imaging is a valuable tool for complex coronary interventions. While complications are rare, the occurrence of ventricular arrhythmias during its use is one of the most...
8.
Rodriguez-Leor O, Cid-Alvarez A, Lopez-Benito M, Gonzalo N, Vilalta V, Diarte De Miguel J, et al.
JACC Cardiovasc Interv
. 2024 Feb;
17(6):756-767.
PMID: 38385926
Background: Intravascular lithotripsy (IVL) has demonstrated effectiveness in the treatment of calcified lesions in selected patients with stable coronary disease. Objectives: The authors sought to assess the performance of coronary...
9.
Nuche J, Ternacle J, Avvedimento M, Cheema A, Veiga-Fernandez G, Munoz-Garcia A, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 Nov;
77(5):396-407.
PMID: 38000627
Introduction And Objectives: There are scarce data on the factors associated with impaired functional status after transcatheter aortic valve replacement (TAVR) and its clinical impact. This study aimed to determine...
10.
Garcia-Touchard A, Sabate M, Gonzalo N, Peral V, Vaquerizo B, Ruiz-Salmeron R, et al.
Cardiovasc Diagn Ther
. 2023 Nov;
13(5):792-804.
PMID: 37941845
Background: Drug-eluting stents (DES) are considered the therapy of choice in ST-segment elevation myocardial infarction (STEMI); however, a low persistent rate of revascularizations and stent thrombosis exist over the time....